Trial intelligence / Profile preview

Esomeprazole in Non-Ulcer Dyspepsia

NCT00222131Phase 2Completed

Sponsor
University of Kansas Medical Center
Start
Oct 2003
Primary completion
Jan 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in dyspepsia comparing Placebo with Esomeprazole (2 arms). Primary endpoint: Percentage of Participants With Satisfactory Relief of Non-ulcer Dyspepsia Symptoms at 8 weeks. Started Oct 2003; status: completed.

02

Drugs

esomeprazole
03

Conditions

dyspepsia

Beyond the preview

Go deeper on NCT00222131.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00222131.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call